MUC1 and COVID-19: In conclusion, our study shows that KL-6 represents a strategic tool of great utility in the diagnostic and therapeutic algorithm of more severe patients infected with SARS-CoV-2, as both a key parameter in the severity quantification of COVID-19 and a prognostic biomarker.